STOCKSCOPE

Plenti Group (ASX: PLT) Hits $613m Lending Record, but Can Profits Keep Pace With Growth?

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:27 Oct 2026
Plenti Group (ASX: PLT) Hits $613m Lending Record, but Can Profits Keep Pace With Growth?

Plenti Group (ASX: PLT) has crossed a significant threshold, writing a record $613 million in loans during the September quarter and reaching its $600 million quarterly lending target two quarters ahead of schedule. The Australian fintech lender is expanding rapidly across automotive, personal and renewable energy finance, but the bigger question is whether its growing loan book can continue translating into higher profits without a deterioration in credit quality or margins.

Key numbers

  • $613 million: Quarterly loan originations, up 29% year on year and 14% on the previous quarter.
  • $3.52 billion: Total loan portfolio at 30 September 2026, up 24% year on year.
  • $89.7 million: Quarterly revenue, up 18% year on year.
  • 96 basis points: Annualised net credit losses, compared with 94 basis points a year earlier.
  • $30.8 million: FY26 cash profit before tax, up 117% from the previous financial year.

The latest development: growth is accelerating

Plenti's second-quarter FY27 update, released on 27 October, shows that its lending momentum has strengthened following a record $536 million in originations in the June quarter.

The latest result is important because the company has already achieved its FY27 objective of reaching a $600 million quarterly origination run-rate. That gives management more time to focus on profitability and operating efficiency rather than simply increasing lending volumes.

Growth is also becoming more diversified. Personal lending generated $186 million in originations, consumer automotive contributed $180 million, commercial lending delivered $129 million, and renewable energy finance reached $117 million.

Renewable energy was the standout performer, with originations more than doubling year on year. Government-backed battery programs are helping drive demand, although the durability of this growth will depend partly on the continuation and effectiveness of those incentives.

Importantly, loan originations represent new lending rather than immediately recognised profit. The economics depend on interest margins, funding costs, credit losses and the expenses associated with servicing the expanding portfolio.

What stands out to us: growth must translate into earnings

Plenti's competitive advantage rests on its proprietary digital lending platform, established broker relationships and funding capabilities. Its partnerships with NAB, Tesla and AGL help extend customer reach, while automated credit assessment and loan processing can improve efficiency as volumes increase.

The financial trajectory is encouraging. In FY26, cash profit before tax more than doubled to $30.8 million, while the operating cost-to-net margin improved to 56.7%. Plenti also generated $20.6 million in corporate cash after funding loan book growth and repaid $12.5 million of corporate debt.

However, lending is capital-intensive. Plenti needs reliable access to wholesale funding and securitisation markets to finance new loans. On 15 October, it priced a $450 million asset-backed securities transaction covering personal and renewable energy loans, following a record $660.5 million automotive transaction in July.

These transactions demonstrate funding capacity, but they do not eliminate refinancing risk or protect margins from rising market funding costs.

What the company is doing now

Plenti is pursuing its Horizon 2 strategy, which focuses on profitable growth across its three core lending divisions, with additional emphasis on commercial automotive finance.

The company is also expanding government-linked renewable energy lending and strengthening its digital infrastructure through artificial intelligence and automated processing. These investments could help it process more applications without increasing operating expenses at the same rate.

Yet pricing remains crucial. Plenti reported an average net interest margin of approximately 5.3% on new originations in the September quarter. Market funding costs rose by around 40 basis points in September, prompting customer pricing increases during September and October.

The ability to pass on higher costs without materially slowing lending demand will be an important test of its business model.

Insight: Is Plenti's growth creating enough value?

We think Plenti is developing into a more credible growth-and-profitability story, rather than simply a fintech expanding its loan book. Its record originations, improving operating efficiency and FY26 cash profit growth provide evidence that scale can translate into stronger earnings. However, the latest quarter does not yet establish that margins will withstand sustained funding pressure. Credit losses also edged higher year on year, although they remain relatively contained. Our assessment will depend on whether Plenti can sustain profit growth while preserving credit quality and generating surplus corporate cash.

What happens next?

The next major milestone is Plenti's first-half FY27 financial results, scheduled for 25 November 2026. The figures should reveal whether the record September quarter is translating into stronger underlying profitability.

Three measures deserve particular attention:

  • Cash profit before tax: continued growth would support the argument that increased lending volumes are generating meaningful earnings.
  • Operating cost-to-net margin: management is targeting a result below 55% for FY27, compared with 56.7% in FY26.
  • Credit losses and net interest margins: stable credit performance and resilient lending spreads would strengthen the quality of reported growth.

At around $0.76 per share, Plenti had a market capitalisation of approximately $135 million. That valuation provides context, but the comparison with FY26 cash earnings needs care because cash profit measures are not equivalent to statutory earnings.

The opportunity is increasingly clear: Plenti is scaling faster than expected. The unanswered question is whether that scale can deliver durable earnings growth without sacrificing lending standards or profitability.

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...